A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Many of these species possess genes that make them resistant to decontamination and radiation, potentially posing a risk of interplanetary contamination. These "extremophile" microorganisms could lead ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Jan 6, 2026 at 8:51 ...

SEATTLE, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...

- Star Seyedkazemi, Pharm.D., chief development officer, expands her responsibilities to lead Adverum’s clinical development, medical affairs and pharmacovigilance teams - REDWOOD CITY, Calif., May 25 ...

Despite the headline jump, local brokers describe a market that still feels slow. As reported by Crain's New York Business, CBRE Vice Chairman William Hartman said demand is "still pretty anemic" even ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Adaptive Biotechnologies Corporation announced that as of January 1, 2025, the new Medicare Clinical Laboratory Fee Schedule includes a payment rate of $2,007 for its clonoSEQ test used for assessing ...

Recent reporting revealed that Russia is rebuilding a major research center for biological weapons. Meanwhile, China is deeply embedded in our critical biotech supply chains, giving the Chinese ...